|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,104 GBX | -1.27% |
|
+0.50% | +14.19% |
| Jul. 15 | Global markets live: Airbus, Burberry, AT&T, Boeing, Vinfast... |  |
| Jul. 15 | AstraZeneca: acquisition of Amolyt Pharma finalized | CF |
Jan 29 (Reuters) - European Medicines Agency (EMA):
* EMA HAS RECOMMENDED GRANTING A CONDITIONAL MARKETING AUTHORISATION FOR COVID-19 VACCINE ASTRAZENECA
* RECOMMENDED GRANTING A CONDITIONAL MARKETING AUTHORISATION FOR COVID-19 VACCINE ASTRAZENECA TO PREVENT COVID-19 IN PEOPLE FROM 18 YEARS OF AGE
* EMA'S SCIENTIFIC EXPERTS CONSIDERED THAT THE VACCINE CAN BE USED IN OLDER ADULTS Source text: (https://bit.ly/39uwOwc) Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +14.19% | 247B | |
| +63.05% | 854B | |
| +39.42% | 636B | |
| -4.78% | 361B | |
| +17.52% | 324B | |
| +8.43% | 301B | |
| +5.81% | 230B | |
| +16.77% | 228B | |
| +14.63% | 177B | |
| +1.08% | 164B |
ASTRAZENECA PLC 
